UAB "PharmaSwiss" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2021 |
|---|
| 10,063,266 |
| 557,213 |
| -454,900 |
| -561,269 |
| -31,078 |
| 35.51 |
| -5.58 |
| 1,975,755 |
| 2,105,923 |
| 0 |
| 4,163,786 |
| 0.14 |
| 1.07 |
| - |
| - |
| -4.54 |
| -456,708 |
| 2022 |
|---|
| 1,241,210 |
| 273,394 |
| 1,076,076 |
| 989,337 |
| 217,916 |
| 100.00 |
| 79.71 |
| 2,965,092 |
| 0 |
| 0 |
| 2,965,092 |
| 2.39 |
| 0.00 |
| - |
| - |
| 86.69 |
| 1,076,054 |
| 2022 |
|---|
| 1,241,210 |
| 273,394 |
| 1,076,076 |
| 989,337 |
| 217,916 |
| 100.00 |
| 79.71 |
| 2,965,092 |
| 0 |
| 0 |
| 2,965,092 |
| 2.39 |
| 0.00 |
| - |
| - |
| 86.69 |
| 1,076,054 |
Turnover (€)
2022
Turnover (€)
1,241,210 €-88 % *
Sales per employee (€)
273,394 €-51 % *
Profit before tax (€)
1,076,076 €337 % *
Net Profit (€)
989,337 €276 % *
Profit per employee (€)
217,916 €801 % *
Total profitability (%)
100.00 %181.61 % *
Net profitability (%)
79.71 %1,528.49 % *
Equity (€)
2,965,092 €50 % *
Amounts Payable And Liabilities (€)
0 €-100 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
2,965,092 €-29 % *
Working capital requirement
2.39 1,607.14 % *
Debt-to-equity ratio
0.00 -100.00 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
86.69 %2,009.47 % *
EBIT (€)
1,076,054 €336 % *
